Evidence map›Paper›PMID 36992238›Full record

ArticleVaccines2023

T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis.

Ayumi Yoshifuji, Masataro Toda, Munekazu Ryuzaki, Emi Oyama, Kan Kikuchi, Toru Kawai, Ken Sakai, Masayoshi Koinuma, Kazuhiko Katayama, Takashi Yokoyama and 16 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 1 country.

Ayumi YoshifujiInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.ORCID 0000-0001-8246-8675
Masataro TodaDivision of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.ORCID 0000-0001-6835-396X
Munekazu RyuzakiInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Emi OyamaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Kan KikuchiInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Toru KawaiInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Ken SakaiInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Masayoshi KoinumaFaculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo 164-8530, Japan.
Kazuhiko KatayamaLaboratory of Viral Infection Control, Ōmura Satoshi Memorial Institute, Graduate School of Infection Control Sciences, Kitasato University, Tokyo 108-8641, Japan.
Takashi YokoyamaDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yuki UeharaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.ORCID 0000-0003-1014-8888
Norio OhmagariInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Yoshihiko KannoInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.ORCID 0000-0003-2481-2372
Hirofumi KonInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Toshio ShinodaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Yaoko TakanoInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Junko TanakaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Kazuhiko HoraInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Yasushi NakazawaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.ORCID 0000-0002-0668-068X
Naoki HasegawaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Norio HanafusaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Fumihiko HinoshitaInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Keita MorikaneInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Shu WakinoInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Hidetomo NakamotoInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Yoshiaki TakemotoInfection Control Committee, The Japanese Society for Dialysis Therapy, Tokyo 113-0033, Japan.
Japanese Society for Dialysis Therapy · JPKeio University · JPKitasato University · JPSaiseikai Central Hospital · JPTeikyo Heisei University · JP

Funding

the Japanese Society for Dialysis Therapy we do not have any number
6 · The paper itself

Abstract

Humoral and cellular responses are critical in understanding immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Here, we evaluated these responses in hemodialysis (HD) patients after the booster vaccination. SARS-CoV-2 immunoglobulin (IgG) levels, neutralizing antibody titers, and the T-SPOT

Indexed as

adverse reactionscellular immunityCOVID-19hemodialysishumoral immunityvaccinationvaccine

Identifiers

PMID36992238
PMCPMC10057502
OpenAlexW4324141456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.